Biology Reference
In-Depth Information
112. Chen J, Shi G, Concepcion FA, Xie G, Oprian D, Chen J. Stable rhodopsin/arrestin
complex leads to retinal degeneration in a transgenic mouse model of autosomal dom-
inant retinitis pigmentosa. J Neurosci . 2006;26:11929- 11937.
113. Ohguro H, Chiba S, Igarashi Y, Matsumoto H, Akino T, Palczewski K. Beta-arrestin
and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients.
Proc Natl Acad Sci USA . 1993;90:3241- 3245.
114. Gorczyca WA, Ejma M, Witkowska D, et al. Retinal antigens are recognized by anti-
bodies present in sera of patients with multiple sclerosis. Ophthalmic Res .
2004;36:120- 123.
115. Forooghian F, Cheung RK, Smith WC, O'connor P, Dosch HM. Enolase and arrestin
are novel nonmyelin autoantigens
in multiple sclerosis.
J Clin Immunol . 2007;
27:388 - 396.
116. Raine CS. Multiple sclerosis: a pivotal role for the T cell in lesion development. Neu-
ropathol Appl Neurobiol . 1991;17:265- 274.
117. Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF. Blindness caused by photorecep-
tor degeneration as a remote effect of cancer. Am J Ophthalmol . 1976;81:606- 613.
118. Adamus G, Chan CC. Experimental autoimmune uveitides: multiple antigens, diverse
diseases. Int Rev Immunol . 2002;21:209 - 229.
119. Misiuk-Hojło M, Ejma M, Gorczyca W, et al. Cancer-associated retinopathy in
patients with breast carcinoma. Arch Immunol Ther Exp . 2007;55:261- 265.
120. Gery
I, Mochizuki M, Nussenblatt RB. Retinal
specific
antigens
and
immunopathogenic processes they provoke. Prog Retin Res . 1986;5:75- 109.
 
 
Search WWH ::




Custom Search